{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:17:03Z","timestamp":1793222223940,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.hrthm.2025.05.049","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T23:21:09Z","timestamp":1754436069000},"page":"e1064-e1074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["SCAI\/HRS technical review on transcatheter left atrial appendage occlusion"],"prefix":"10.1016","volume":"22","author":[{"given":"Edmond M.","family":"Cronin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Filby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Field","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan","family":"Huded","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia H.","family":"Indik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Armah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Firestone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Fix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Senerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yngve","family":"Falck-Ytter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.hrthm.2025.05.049_bib1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear","year":"1996","journal-title":"Ann Thorac Surg"},{"issue":"8","key":"10.1016\/j.hrthm.2025.05.049_bib2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.hrthm.2025.05.049_bib3","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus Warfarin in Patients with Atrial Fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.hrthm.2025.05.049_bib4","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.hrthm.2025.05.049_bib5","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.hrthm.2025.05.049_bib6","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.hrthm.2025.05.049_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.hrthm.2025.05.049_bib8","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.hrthm.2025.05.049_bib9","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jacc.2019.12.040","article-title":"The NCDR left atrial appendage occlusion registry","volume":"75","author":"Freeman","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.hrthm.2025.05.049_bib10","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"Amplatzer amulet left atrial appendage occluder versus watchman device for stroke prophylaxis (Amulet IDE): a randomized, controlled trial","volume":"144","author":"Lakkireddy","year":"2021","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hrthm.2025.05.049_bib11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jacep.2021.10.001","article-title":"Intracardiac echocardiography-guided left atrial appendage closure with a novel foam-based conformable device: safety and 1-year outcomes","volume":"8","author":"Turagam","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"issue":"11","key":"10.1016\/j.hrthm.2025.05.049_bib12","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.jcin.2023.04.028","article-title":"Transcatheter left atrial appendage exclusion: preclinical and early clinical results with the laminar device","volume":"16","author":"Wong","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.hrthm.2025.05.049_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jcin.2019.08.054","article-title":"Expert recommendations on cardiac computed tomography for planning transcatheter left atrial appendage occlusion","volume":"13","author":"Korsholm","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.hrthm.2025.05.049_bib14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jcin.2022.10.024","article-title":"Intracardiac echocardiography to guide watchman FLX implantation: the ICE LAA study","volume":"16","author":"Nielsen-Kudsk","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"10.1016\/j.hrthm.2025.05.049_bib15","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jacc.2024.05.067","article-title":"Anticoagulation alone vs anticoagulation plus aspirin or DAPT following left atrial appendage occlusion","volume":"84","author":"Reinhardt","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.hrthm.2025.05.049_bib16","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1016\/j.jcin.2023.08.013","article-title":"DAPT Is Comparable to OAC following LAAC with WATCHMAN FLX: a national registry analysis","volume":"16","author":"Coylewright","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"21","key":"10.1016\/j.hrthm.2025.05.049_bib17","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.jcin.2021.07.031","article-title":"Half-dose direct oral anticoagulation versus standard antithrombotic therapy after left atrial appendage occlusion","volume":"14","author":"Della Rocca","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.hrthm.2025.05.049_bib18","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jacep.2022.03.001","article-title":"Clinical impact of residual leaks following left atrial appendage occlusion: insights from the NCDR LAAO registry","volume":"8","author":"Alkhouli","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"issue":"5","key":"10.1016\/j.hrthm.2025.05.049_bib19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jacc.2022.04.062","article-title":"Impact of peridevice leak on 5-year outcomes after left atrial appendage closure","volume":"80","author":"Dukkipati","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hrthm.2025.05.049_bib20","article-title":"SCAI\/HRS Expert consensus statement on transcatheter left atrial appendage closure","volume":"2","author":"Saw","year":"2023","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"issue":"1","key":"10.1016\/j.hrthm.2025.05.049_bib21","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the Diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.hrthm.2025.05.049_bib22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.hrthm.2025.05.049_bib23","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2025.05.049_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2025.05.049_bib25","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2025.05.049_bib26","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","first-page":"143","article-title":"Choosing effect measures and computing estimates of effect","author":"Higgins","year":"2019"},{"issue":"4","key":"10.1016\/j.hrthm.2025.05.049_bib27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.hrthm.2025.05.049_bib28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"10.1016\/j.hrthm.2025.05.049_bib30","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/ckj\/sfad221","article-title":"Long-term safety and efficacy of left atrial appendage occlusion in dialysis patients with atrial fibrillation: a multi-center, prospective, open label, observational study","volume":"16","author":"Genovesi","year":"2023","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1016\/j.hrthm.2025.05.049_bib31","first-page":"330","article-title":"Single-operator left atrial appendage occlusion utilizing conscious sedation TEE, lack of outpatient pre-imaging, and same-day expedited discharge (SOLO-CLOSE): a comparison with conventional approach","volume":"104","author":"Golzarian","year":"2024","journal-title":"Catheter Cardiovasc Interv"},{"issue":"11","key":"10.1016\/j.hrthm.2025.05.049_bib32","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jcin.2023.02.027","article-title":"Impact of preprocedural computed tomography on left atrial appendage closure success: a Swiss-Apero trial subanalysis","volume":"16","author":"Galea","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.hrthm.2025.05.049_bib33","first-page":"401","article-title":"Prospective, randomized comparison of 3-dimensional computed tomography guidance versus TEE data for left atrial appendage occlusion (PRO3DLAAO)","volume":"92","author":"Eng","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.hrthm.2025.05.049_bib34","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.jacep.2023.08.004","article-title":"Intracardiac vs transesophageal echocardiography for left atrial appendage occlusion with watchman FLX in the U.S","volume":"9","author":"Ferro","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"issue":"2","key":"10.1016\/j.hrthm.2025.05.049_bib35","first-page":"331","article-title":"Intracardiac versus transesophageal echocardiography for left atrial appendage occlusion with watchman","volume":"90","author":"Frangieh","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.hrthm.2025.05.049_bib36","first-page":"1572","article-title":"In-hospital outcomes of transesophageal versus intracardiac echocardiography guided left atrial appendage closure","volume":"99","author":"Morcos","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"issue":"11","key":"10.1016\/j.hrthm.2025.05.049_bib37","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jcin.2018.05.008","article-title":"Intracardiac versus transesophageal echocardiographic guidance for left atrial appendage occlusion: the LAAO Italian multicenter registry","volume":"11","author":"Berti","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"21","key":"10.1016\/j.hrthm.2025.05.049_bib38","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.jcin.2017.06.057","article-title":"Intracardiac echocardiography from the left atrium for procedural guidance of transcatheter left atrial appendage occlusion","volume":"10","author":"Korsholm","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.hrthm.2025.05.049_bib39","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.repc.2018.03.009","article-title":"Registry of left atrial appendage closure and initial experience with intracardiac echocardiography","volume":"37","author":"Reis","year":"2018","journal-title":"Rev Port Cardiol (Engl Ed)"},{"key":"10.1016\/j.hrthm.2025.05.049_bib40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijcard.2022.09.066","article-title":"Looking for optimal antithrombotic strategy after transcatheter left atrial appendage occlusion: a real-world comparison of different antiplatelet regimens","volume":"371","author":"Vignali","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2025.05.049_bib41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.amjcard.2020.08.013","article-title":"Safety and efficacy of single versus dual antiplatelet therapy after left atrial appendage occlusion","volume":"134","author":"Patti","year":"2020","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.hrthm.2025.05.049_bib42","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.3390\/jcm10091959","article-title":"Role of different antithrombotic regimens after percutaneous left atrial appendage occlusion: a large single center experience","volume":"10","author":"Mazzone","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.hrthm.2025.05.049_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijcard.2020.11.045","article-title":"Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter study","volume":"328","author":"Casu","year":"2021","journal-title":"Int J Cardiol"},{"issue":"11","key":"10.1016\/j.hrthm.2025.05.049_bib44","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jcin.2019.02.003","article-title":"Incidence, characterization, and clinical impact of device-related thrombus following left atrial appendage occlusion in the prospective global AMPLATZER amulet observational study","volume":"12","author":"Aminian","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"10.1016\/j.hrthm.2025.05.049_bib45","first-page":"E1019","article-title":"Incidence, predictors and outcomes of device-related thrombus after left atrial appendage closure with the WATCHMAN device-Insights from the EWOLUTION real world registry","volume":"97","author":"Sedaghat","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"issue":"31","key":"10.1016\/j.hrthm.2025.05.049_bib46","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1093\/eurheartj\/ehv730","article-title":"Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry","volume":"37","author":"Boersma","year":"2016","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.hrthm.2025.05.049_bib47","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad237","article-title":"Mechanisms, predictors, and evolution of severe peri-device leaks with two different left atrial appendage occluders","volume":"25","author":"Lakkireddy","year":"2023","journal-title":"Europace"},{"issue":"10","key":"10.1016\/j.hrthm.2025.05.049_bib48","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jacc.2011.11.028","volume":"59","author":"Viles-Gonzalez","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"9689","key":"10.1016\/j.hrthm.2025.05.049_bib49","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.hrthm.2025.05.049_bib50","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.009039","article-title":"Short-term oral anticoagulation versus antiplatelet therapy following transcatheter left atrial appendage closure","volume":"13","author":"Asmarats","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.hrthm.2025.05.049_bib51","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.006841","article-title":"Evaluating real-world clinical outcomes in atrial fibrillation patients receiving the WATCHMAN left atrial appendage closure technology: final 2-year outcome data of the EWOLUTION trial focusing on history of stroke and hemorrhage","volume":"12","author":"Boersma","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"23","key":"10.1016\/j.hrthm.2025.05.049_bib52","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1016\/j.jcin.2020.06.056","article-title":"Procedural and short-term results with the new watchman FLX left atrial appendage occlusion device","volume":"13","author":"Cruz-Gonz\u00e1lez","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.hrthm.2025.05.049_bib53","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005997","article-title":"Device thrombosis after percutaneous left atrial appendage occlusion is related to patient and procedural characteristics but not to duration of postimplantation dual antiplatelet therapy","volume":"11","author":"Pracon","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.hrthm.2025.05.049_bib54","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.010195","article-title":"Device-related thrombus after left atrial appendage closure: data on thrombus characteristics, treatment strategies, and clinical outcomes from the EUROC-DRT-registry","volume":"14","author":"Sedaghat","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.hrthm.2025.05.049_bib55","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/CIRCULATIONAHA.118.035090","article-title":"Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes","volume":"138","author":"Dukkipati","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hrthm.2025.05.049_bib56","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jacep.2022.07.014","article-title":"Incidence, predictors, and clinical outcomes of device-related thrombus in the amulet IDE trial","volume":"9","author":"Schmidt","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2025.05.049_bib57","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ahj.2023.05.022","article-title":"Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation","volume":"264","author":"Kar","year":"2023","journal-title":"Am Heart J"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527125025093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527125025093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T07:32:22Z","timestamp":1777793542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527125025093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":56,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1547527125025093"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2025.05.049","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SCAI\/HRS technical review on transcatheter left atrial appendage occlusion","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2025.05.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Society for Cardiovascular Angiography & Interventions Foundation and Heart Rhythm Society. Published by Elsevier Inc. on behalf of the Society for Cardiovascular Angiography & Interventions Foundation and Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}